Search

Your search keyword '"Fagard, Catherine"' showing total 152 results

Search Constraints

Start Over You searched for: Author "Fagard, Catherine" Remove constraint Author: "Fagard, Catherine"
152 results on '"Fagard, Catherine"'

Search Results

1. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial

4. Responsible scientific research at Inserm: a field study

5. Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course

6. Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial

7. Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression

8. Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial)

11. Information Sheets and Informed Consent Forms for Clinical Study Participants: Towards Standardised Recommendations?

12. Note d’information et consentement des patients participant à des essais cliniques : vers des recommandations standardisées ?

14. Relevance of HIV-1-Specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3

15. Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial

27. A Prospective Trial of Structured Treatment Interruptions in Human Immunodeficiency Virus Infection

30. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial

31. Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course

32. Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial

33. Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression

34. Role of Baseline HIV-1 DNA Level in Highly-Experienced Patients Receiving Raltegravir, Etravirine and Darunavir/Ritonavir Regimen

35. Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM).

36. Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial

37. Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial)

39. Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial

41. Note d’information et consentement des patients participant à des essais cliniques : vers des recommandations standardisées ?

42. Information Sheets and Informed Consent Forms for Clinical Study Participants: Towards Standardised Recommendations?

44. Relevance of HIV-1-Specific CD4+ Helper T-Cell Responses During Structured Treatment Interruptions in Patients With CD4+ T-Cell Nadir Above 400/mm³.

45. Functional Discrepancies in HIV-Specific CD8[sup +] T-Lymphocyte Populations Are Related to Plasma Virus Load.

46. Intensification of Antiretroviral Therapy through Addition of Enfuvirtide in Naive HIV-1-Infected Patients with Severe Immunosuppression Does Not Improve Immunological Response: Results of a Randomized Multicenter Trial (ANRS 130 Apollo)

47. Drug Resistance Mutations during Structured Treatment Interruptions

48. Functional Discrepancies in HIV-Specific CD8+T-Lymphocyte Populations Are Related to Plasma Virus Load

50. HIV-2 X4 tropism is associated with lower CD4cell count in treatment-experienced patients

Catalog

Books, media, physical & digital resources